Clinical Trials Logo

Filter by:
  • Recruiting  
  • « Prev · Page [5]
NCT ID: NCT00903110 Recruiting - IGF1 Deficiency Clinical Trials

Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).

Start date: December 9, 2008
Phase:
Study type: Observational [Patient Registry]

The Increlex® Global Registry is a descriptive, multicenter, observational, prospective, open-ended, non interventional, post-authorisation surveillance registry. The main purpose of this global registry is to collect, analyse and report safety data during and up to at least 5 years after the end of treatment in children and adolescents receiving Increlex® therapy for SPIGFD according to the locally approved product information.